It Started With A Problem
Brain cancer is a complex and deadly disease; treatment decisions rely on interpreting multiple tumor characteristics and changes on MRIs throughout the care process. Dr. Aly Abayazeed, our Co-Founder, former Chief Medical Officer, and a practicing Neuroradiologist, was searching for a more insightful, empirical and consistent method to analyze brain tumor MRIs to help make the best quality treatment decisions for his patients.
Seeing no clinically-available products, the solution was to build a new platform tailored to treating teams to address these issues, and many more.
And thus began the Neosoma story...
Filter Team:
Ken Kolodziej
Co-Founder and Chief Executive Officer
Benjamin Ellingson, PhD
Scientific Advisor: R&D
Kambiz Nael, MD
Medical Advisor
Nicklaus Khan, MD
Medical Advisor
Michael Hill
Chief Technology Officer
Katherine Kacena, PhD
Biostatistics
Richard Stark
Strategic Advisor
John Liedtky
Chief Strategy and Commercial Officer
Michael Müller
Senior AI Engineer
Roger Stupp, MD
Medical Advisor
Mauricio Reyes, PhD
AI Development
Jerrold Boxerman, MD
Medical Advisor
Ashley Ghiaseddin, MD
Medical Advisor